Live feed
Filing
SC 13D
SC 13D0001144204-14-034026·Eloxx Pharmaceuticals, Inc.
Schedule 13D ownership disclosure
SENESCO TECHNOLOGIES INC
Security class unavailable · CUSIP: 817208507
Event date: 2014-05-16
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,400,970
- Percent of class
- 9.9000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001144204-14-034026
- Form type
- SC 13D
- Filer
- Eloxx Pharmaceuticals, Inc.
- CIK
- CIK 1035354
- Filed
- May 29, 2014
- Reporting period
- May 16, 2014
- Description
- Schedule 13D beneficial ownership